Physician
Frederick Health Hospital INC
Frederick Health Hospital INC was paid $999K by Medicaid between Jan 2018 and Nov 2024, across 87 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 38% of everything it billed.
33Billing provider infoFREDERICK HEALTH HOSPITAL INC
FREDERICK, MD 21702
FREDERICK, MD 21702
33aNPI1982600771assigned 06/27/2005
33bProvider typeNeuromusculoskeletal Medicine & OMM Physician
28Total paid$999K
24GClaims136,181
24DCodes billed87
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 231 | $7K | |
| 2019 | 206 | $4K | |
| 2020 | 18,736 | $212K | |
| 2021 | 37,301 | $463K | |
| 2022 | 33,041 | $199K | |
| 2023 | 23,085 | $53K | |
| 2024incomplete | 23,581 | $61K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 38% | 11,311 | 6,298 | $382K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4.9% | 996 | 626 | $49K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.1% | 452 | 332 | $41K |
| 80053 | Comprehensive metabolic panel | 4.0% | 13,957 | 7,704 | $40K |
| 80061 | Lipid panel | 3.5% | 7,945 | 4,763 | $35K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.4% | 8,276 | 4,830 | $34K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.2% | 3,928 | 2,308 | $32K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2.5% | 193 | 143 | $25K |
| 71250 | 2.4% | 491 | 397 | $24K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.3% | 7,329 | 4,439 | $23K |
| 71046 | Radiologic examination, chest; 2 views | 2.0% | 1,949 | 1,426 | $20K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.9% | 567 | 379 | $19K |
75 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 9,475 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 1,365 | $18K |
| 76642 | 1.7% | 684 | $17K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.6% | 6,694 | $16K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 19,917 | $16K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 1.4% | 970 | $14K |
| 77065 | Tomosynthesis, mammo | 1.2% | 265 | $12K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1.1% | 217 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.1% | 1,218 | $11K |
| 84439 | 1.1% | 3,410 | $11K | |
| 82728 | 1.1% | 2,577 | $11K | |
| 82607 | 1.0% | 2,357 | $10K | |
| 84466 | <1% | 2,254 | $9K | |
| 77066 | Tomosynthesis, mammo | <1% | 143 | $8K |
| 85027 | <1% | 3,887 | $8K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 752 | $6K |
| 83540 | <1% | 2,434 | $5K | |
| 82746 | <1% | 1,568 | $5K | |
| 80050 | General health panel | <1% | 1,496 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,488 | $4K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 58 | $4K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 119 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 726 | $3K |
| 72110 | <1% | 163 | $3K | |
| 84481 | <1% | 477 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,807 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 57 | $3K |
| 76770 | <1% | 78 | $3K | |
| 81001 | <1% | 2,335 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 488 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 356 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 249 | $2K |
| 82570 | <1% | 1,202 | $2K | |
| 73560 | <1% | 176 | $2K | |
| 84153 | <1% | 363 | $2K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 21 | $2K |
| 82043 | <1% | 858 | $1K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 73 | $1K |
| 86780 | <1% | 259 | $1K | |
| 87077 | <1% | 836 | $997.79 | |
| 85610 | <1% | 717 | $982.25 | |
| 73030 | <1% | 112 | $905.90 | |
| 76536 | <1% | 52 | $893.28 | |
| 86140 | <1% | 515 | $854.18 | |
| 86803 | <1% | 246 | $821.52 | |
| 86038 | <1% | 219 | $764.01 | |
| 87070 | <1% | 478 | $722.04 | |
| 83970 | <1% | 40 | $697.62 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 81 | $689.00 |
| 85652 | <1% | 677 | $521.60 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 55 | $516.75 |
| 83735 | <1% | 297 | $506.71 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 29 | $444.60 |
| 87186 | <1% | 280 | $430.35 | |
| 0353U | <1% | 77 | $358.50 | |
| 77062 | <1% | 24 | $346.22 | |
| 87150 | <1% | 71 | $333.81 | |
| 86618 | <1% | 77 | $332.85 | |
| 87340 | <1% | 115 | $297.90 | |
| 73630 | <1% | 26 | $295.65 | |
| 72081 | <1% | 21 | $272.41 | |
| 85730 | <1% | 133 | $269.54 | |
| 82652 | <1% | 20 | $232.40 | |
| 73130 | <1% | 28 | $219.20 | |
| 82784 | <1% | 32 | $210.71 | |
| 84403 | <1% | 25 | $187.02 | |
| 80076 | <1% | 83 | $168.42 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 132 | $142.63 |
| 84436 | <1% | 24 | $80.88 | |
| 84146 | <1% | 16 | $70.17 | |
| 80069 | <1% | 21 | $62.88 | |
| 86706 | <1% | 20 | $51.84 | |
| 84702 | <1% | 18 | $36.36 | |
| 83550 | 0% | 136 | $0.00 | |
| 0352U | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJACOBS, HANNAH (CFO AND SR. VP)
Parent organizationFREDERICK HEALTH HOSPITAL INC